Dermapharm Holding SECHIX:DMPD 80 Days Inventory is 318.62 as of Mar. 2026, which is 40% above its 10-year median of 227.15. GuruFocus rates CHIX:DMPD with a GF Score™ of 80/100 and a GF Value™ of €38.59. The stock has 9 warning signs investors should review. Among 916 Drug Manufacturers companies, Dermapharm Holding SE ranks worse than 87.88% on this metric.
The historical rank and industry rank for Dermapharm Holding SE's Days Inventory or its related term are showing as below:
CHIX:DMPd'
s Days Inventory Range Over the Past 10 Years
Min: 121.06 Med: 227.15 Max: 334.22
Current: 334.22
During the past 13 years, Dermapharm Holding SE's highest Days Inventory was 334.22. The lowest was 121.06. And the median was 227.15.
CHIX:DMPd's Days Inventory is ranked worse than 87.88% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs CHIX:DMPd: 334.22
Inventory Turnover measures how fast the company turns over its inventory within a year.
Dermapharm Holding SE's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dermapharm Holding SE's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.12.
Dermapharm Holding SE (CHIX:DMPd) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Dermapharm Holding SE's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dermapharm Holding SE's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Dermapharm Holding SE Days Inventory Related Terms
Dermapharm Holding SE Days Inventory Historical Data
* Premium members only.
The historical data trend for Dermapharm Holding SE's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:DMPD vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dermapharm Holding SE Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Days Inventory distribution charts can be found below:
* The bar in red indicates where Dermapharm Holding SE's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dermapharm Holding SE (CHIX:DMPD) has a Days Inventory of 318.62 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dermapharm Holding SE and its competitors. This is 40% above median its historical median of 227.15. Over the past decade, Dermapharm Holding SE's Days Inventory has ranged from 121.06 to 334.22. According to the industry distribution chart, Dermapharm Holding SE ranks #805 out of 916 companies in the Drug Manufacturers industry, placing it in the top 87.9%.
Is Dermapharm Holding SE's Days Inventory too high?
Dermapharm Holding SE's current Days Inventory of 318.62 is 40% above median its 10-year median of 227.15. Over the past 10 years, this metric has ranged from a low of 121.06 to a high of 334.22. The Drug Manufacturers industry median Days Inventory is 164.43. Dermapharm Holding SE's value of 318.62 is 93.8% above this industry median. Based on the distribution chart, Dermapharm Holding SE ranks #805 out of 916 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Dermapharm Holding SE has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Dermapharm Holding SE ranks #805 out of 916 companies for Days Inventory. This places Dermapharm Holding SE in the lower half of its industry. The industry median Days Inventory is 164.43. Dermapharm Holding SE's value of 318.62 is 93.8% above this benchmark. Historically, Dermapharm Holding SE's own Days Inventory has ranged from 121.06 to 334.22 over the past decade. While the company's 10-year median is 227.15 vs. the industry median of 164.43, Dermapharm Holding SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dermapharm Holding SE's current Days Inventory of 318.62 is 93.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dermapharm Holding SE and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dermapharm Holding SE's current Days Inventory is 318.62, which is 40% above median its own 10-year median of 227.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Dermapharm Holding SE (CHIX:DMPD) has a current Days Inventory of 318.62. The stock's GF Value™ is €38.59, compared to a current price of €46.18 — trading 19.7% above its estimated fair value. The current Days Inventory is 318.62, which is 40% above median its 10-year median of 227.15 and 93.8% above the Drug Manufacturers industry median of 164.43. Dermapharm Holding SE's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Dermapharm Holding SE (CHIX:DMPD), the current Days Inventory is 318.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dermapharm Holding SE (CHIX:DMPD) Overvalued in 2026?
Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued.
The current stock price of €46.18 is trading 19.7% above its estimated GF Value™ of €38.59.
Key valuation signals for CHIX:DMPD:
Days Inventory: 318.62 (40% above median its 10-year median of 227.15)
GF Value™: €38.59 vs. price of €46.18 (19.7% above fair value)
Industry Position: 93.8% above the Drug Manufacturers median (#805 of 916)
No single metric tells the full story. See the CHIX:DMPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
80GF Score
Get the complete analysis for CHIX:DMPD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:DMPD has been successfully added to your 
